Skip to main content

Table 3 Data on the clinical daptomycin use in patients with staphylococcal periprosthetic joint infection

From: Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection 

Study No of patients Daptomycin dose (median, mg/kg/day) Daptomycin duration (median, days) Adverse event (%) Success rate (%)
Antony et al. [29] (2006) 8 6.0 42 6.5 75.0
Rao et al. [21] (2006) 11 4.0 42 NA 54.5
Antony et al. [28] (2009) 30 6.0 37 3.3 66.7
Corona et al. [16] (2012) 14 6.6 44 21.4 78.6
Byren et al. [17] (2012) 24 6.0 42 8.0 58.3
13 8.0 42 16.7 60.9
Our study 16 8.3 14 6.3 87.5